ID

41452

Description

Study ID: 107671 Clinical Study ID: 107671 Study Title: EGF107671 – A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00437073 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: N/A Trade Name: capecitabine, topotecan, lapatinib Study Indication: Neoplasms, Breast; Recurrent Brain Metastases

Keywords

  1. 10/13/20 10/13/20 -
Copyright Holder

GlaxoSmithKline

Uploaded on

October 13, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Lapatinib + Topotecan or + Capecitabine in Recurrent Brain Metastases from Breast Cancer; NCT00437073

Survival Follow-Up

  1. StudyEvent: ODM
    1. Survival Follow-Up
Date of Visit/Assessment
Description

Date of Visit/Assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Description

Date of visit; Assessment Date

Data type

date

Alias
UMLS CUI [1]
C1320303
UMLS CUI [2]
C2985720
Survival Follow-Up
Description

Survival Follow-Up

Alias
UMLS CUI-1
C1522577
UMLS CUI-2
C0038952
Is the subject alive?
Description

Alive (finding)

Data type

text

Alias
UMLS CUI [1]
C2584946
Date of Contact
Description

Alive (finding), Date last contact

Data type

date

Alias
UMLS CUI [1,1]
C2584946
UMLS CUI [1,2]
C0805839
Has the subject started any new anti-cancer therapy since the last contact?
Description

Cancer treatment, New

Data type

text

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205314
Yes, Start Date
Description

Cancer treatment, New, Start Date

Data type

date

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205314
UMLS CUI [1,3]
C0808070

Similar models

Survival Follow-Up

  1. StudyEvent: ODM
    1. Survival Follow-Up
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Date of Visit/Assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit; Assessment Date
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
C2985720 (UMLS CUI [2])
Item Group
Survival Follow-Up
C1522577 (UMLS CUI-1)
C0038952 (UMLS CUI-2)
Item
Is the subject alive?
text
C2584946 (UMLS CUI [1])
Code List
Is the subject alive?
CL Item
Yes, complete Date of Contact (1)
CL Item
No, complete Death and Study Conclusion forms (2)
Alive (finding), Date last contact
Item
Date of Contact
date
C2584946 (UMLS CUI [1,1])
C0805839 (UMLS CUI [1,2])
Item
Has the subject started any new anti-cancer therapy since the last contact?
text
C0920425 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
Code List
Has the subject started any new anti-cancer therapy since the last contact?
CL Item
Yes, complete Start Date (1)
CL Item
No (2)
Cancer treatment, New, Start Date
Item
Yes, Start Date
date
C0920425 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial